![](/img/cover-not-exists.png)
307PRetrospective observational study to evaluate the use of halaven plus trastuzumab for the treatment of HER2(+) metastatic breast cancer (MBC) in Spain: HALATRUST study
Echarri González, M.J., Ayala de la Peña, F., Márquez Vázquez, R., García-Saenz, J.A., Galve Calvo, E., Illarramendi Mañas, J.J., Millastre Bocos, E., Margelí Vila, M., Sánchez Rovira, P., Chacón LópeVolume:
28
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx365.070
Date:
September, 2017
File:
PDF, 94 KB
2017